Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Debt / NOTE 0.250% 1/1
-
Number of holders
-
36
-
Total 13F principal, excl. options
-
298,643,089
-
Principal change
-
+4,132,183
-
Total reported value, excl. options
-
$201,340,104
-
Value change
-
-$2,525,738
-
Number of buys
-
20
-
Number of sells
-
-14
-
Price
-
$0.6657
Significant Holders of NEOGENOMICS INC - NOTE 0.250% 1/1 as of Q1 2022
43 filings reported holding 64049MAB6 - NEOGENOMICS INC - NOTE 0.250% 1/1 as of Q1 2022.
NEOGENOMICS INC - NOTE 0.250% 1/1 has 36 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $298,643,089 of principal
.
Largest 10 bondholders include Linden Advisors LP ($103,133,000 of principal), CALAMOS ADVISORS LLC ($46,391,000 of principal), CAMDEN ASSET MANAGEMENT L P /CA ($31,852,000 of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($28,555,000 of principal), PUTNAM INVESTMENTS LLC ($12,721,000 of principal), GOLDMAN SACHS GROUP INC ($12,589,000 of principal), FRANKLIN RESOURCES INC ($12,500,000 of principal), Diameter Capital Partners LP ($7,000,000 of principal), Invesco Ltd. ($6,275,000 of principal), and AXA S.A. ($4,900,000 of principal).
This table shows the top 36 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.